Self-Amplifying RNA Cancer Immunotherapy Platforms Market Growth, Analysis with Impact of COVID-19 top Companies, Trends, Future Opportunity Analysis By FMI
NEWARK, DE | The Self-Amplifying RNA Cancer Immunotherapy Platforms Market was valued at USD 94.0 million in 2025 and is expected to reach USD 112.0 million in 2026. Expanding at a CAGR of 19.10%, the market is projected to achieve USD 643.2 million by 2036. This growth reflects a critical shift in oncology toward dose-sparing RNA technologies that address systemic toxicity...
0 Comments 0 Shares 89 Views 0 Reviews